1 | CNTN4, MMP2, SNTB1
|
| Single nucleotide polymorphisms in an Indian cohort and association of CNTN4, MMP2 and SNTB1 variants with oral cancer.
|
| Yete S, Pradhan S, Saranath D.
|
| Cancer Genet 214-215:16-25. doi: 10.1016/j.cancergen.2017.03.006. Epub 2017 Mar 23.
2017
|
2 | CDH2, INVS, MMP2, MMP9, VIM
|
| Inversin correlates with the malignant phenotype of non-small cell lung cancer and promotes the invasiveness of lung cancer cells.
|
| Jiang GY, Zhang Y, Zhang XP, Lin XY, Yu JH, Wang EH.
|
| Tumour Biol 39(6):1010428317691177. doi: 10.1177/1010428317691177.
2017
|
3 | MMP2, PTK2, SERPINB1
|
| Serine protease inhibitor (SERPIN) B1 suppresses cell migration and invasion in glioma cells.
|
| Huasong G, Zongmei D, Jianfeng H, Xiaojun Q, Jun G, Sun G, Donglin W, Jianhong Z.
|
| Brain Res 1600:59-69. doi: 10.1016/j.brainres.2014.06.017. Epub 2014 Jun 23.
2015
|
4 | GKN1, MMP2
|
| GKN1 inhibits cell invasion in gastric cancer by inactivating the NF-kappaB pathway.
|
| Xing R, Cui JT, Xia N, Lu YY.
|
| Discov Med Feb;19(103):65-71 2015
|
5 | ID4, MMP2
|
| Id4 suppresses MMP2-mediated invasion of glioblastoma-derived cells by direct inactivation of Twist1 function.
|
| Rahme GJ, Israel MA.
|
| Oncogene ncogene. 2014 Jan 13. doi: 10.1038/onc.2013.531. [Epub ahead of print]
2014
|
6 | MMP14, MMP2, TACR1
|
| Neurokinin-1 receptor directly mediates glioma cell migration by up-regulation of matrix metalloproteinase-2 (MMP-2) and membrane type 1-matrix metalloproteinase (MT1-MMP).
|
| Mou L, Kang Y, Zhou Y, Zeng Q, Song H, Wang R.
|
| J Biol Chem 288(1):306-18. doi: 10.1074/jbc.M112.389783. Epub 2012 Nov 19.
2013
|
7 | CAPN7, MMP2, TFAP2A
|
| CAPN 7 promotes the migration and invasion of human endometrial stromal cell by regulating matrix metalloproteinase 2 activity.
|
| Liu H, Jiang Y, Jin X, Zhu L, Shen X, Zhang Q, Wang B, Wang J, Hu Y, Yan G, Sun H.
|
| Reprod Biol Endocrinol 11:64. doi: 10.1186/1477-7827-11-64.
2013
|
8 | MMP2, MMP9, SPARC
|
| The expression of SPARC in human intracranial aneurysms and its relationship with MMP-2/-9.
|
| Li B, Li F, Chi L, Zhang L, Zhu S.
|
| PLoS One 8(3):e58490. doi: 10.1371/journal.pone.0058490. Epub 2013 Mar 14.
2013
|
9 | MMP2
|
| Matrix metalloproteinase (MMP)-2 gene polymorphisms affect circulating MMP-2 levels in patients with migraine with aura.
|
| Gonçalves FM, Martins-Oliveira A, Lacchini R, Belo VA, Speciali JG, Dach F, Tanus-Santos JE.
|
| Gene 512(1):35-40. doi: 10.1016/j.gene.2012.09.109. Epub 2012 Oct 5.
2013
|
10 | MMP2, NAO
|
| Loss of MMP-2 in murine osteoblasts upregulates osteopontin and bone sialoprotein expression in a circuit regulating bone homeostasis.
|
| Mosig RA, Martignetti JA.
|
| Dis Model Mech 6(2):397-403. doi: 10.1242/dmm.007914. Epub 2012 Aug 23.
2013
|
11 | HDAC10, MMP2, MMP9
|
| Histone deacetylase (HDAC) 10 suppresses cervical cancer metastasis through inhibition of matrix metalloproteinase (MMP) 2 and 9 expression.
|
| Song C, Zhu S, Wu C, Kang J.
|
| J Biol Chem 288(39):28021-33. doi: 10.1074/jbc.M113.498758. Epub 2013 Jul 29.
2013
|
12 | BEX2, CDH2, MMP2
|
| Bex2 is critical for migration and invasion in malignant glioma cells.
|
| Zhou X, Xu X, Meng Q, Hu J, Zhi T, Shi Q, Yu R.
|
| J Mol Neurosci 50(1):78-87. doi: 10.1007/s12031-012-9864-8. Epub 2012 Aug 3.
2013
|
13 | MMP2, MMP9, NFATC1, SKIL, SMAD3
|
| Cooperative involvement of NFAT and SnoN mediates transforming growth factor-β (TGF-β) induced EMT in metastatic breast cancer (MDA-MB 231) cells.
|
| Sengupta S, Jana S, Biswas S, Mandal PK, Bhattacharyya A.
|
| Clin Exp Metastasis 30(8):1019-31. doi: 10.1007/s10585-013-9600-y. Epub 2013 Jul 6.
2013
|
14 | MMP14, MMP2, TIMP2
|
| MT1-MMP regulates MMP-2 expression and angiogenesis-related functions in human umbilical vein endothelial cells
|
| Lee H, Chang KW, Yang HY, Lin PW, Chen SU, Huang YL.
|
| Biochem Biophys Res Commun. Jul 26;437(2):232-8. doi: 10.1016/j.bbrc.2013.06.046. Epub 2013 Jun 21. 2013
|
15 | MMP2, MMP9
|
| Matrix metalloproteinase-9 regulates survival of neurons in newborn hippocampus.
|
| Murase S, McKay RD.
|
| J Biol Chem 287(15):12184-94. doi: 10.1074/jbc.M111.297671. Epub 2012 Feb 20.
2012
|
16 | MMP14, MMP2, WINCH1, WINCH2
|
| Mutation of Membrane Type-1 Metalloproteinase, MT1-MMP, Causes the Multicentric Osteolysis and Arthritis Disease Winchester Syndrome.
|
| Evans BR, Mosig RA, Lobl M, Martignetti CR, Camacho C, Grum-Tokars V, Glucksman MJ, Martignetti JA.
|
| Am J Hum Genet 91(3):572-6. Epub 2012 Aug 23.
2012
|
17 | MMP14, MMP2, TIMP2
|
| Is matrix metalloproteinase required in postnatal testicular tubules for germ cell maturation?
|
| Li R, Zhang JG, Churchill J, Sourial M, Southwell BR, Hutson JM.
|
| J Pediatr Surg 47(9):1724-9. doi: 10.1016/j.jpedsurg.2012.03.062.
2012
|
18 | MMP2, PAK4
|
| Functional cooperativity by direct interaction between PAK4 and MMP-2 in the regulation of anoikis resistance, migration and invasion in glioma.
|
| Kesanakurti D, Chetty C, Rajasekhar Maddirela D, Gujrati M, Rao JS.
|
| Cell Death Dis 3:e445. doi: 10.1038/cddis.2012.182.
2012
|
19 | MMP2
|
| MMP2 activity is critical for TGFβ2-induced matrix contraction--implications for fibrosis.
|
| Eldred JA, Hodgkinson LM, Dawes LJ, Reddan JR, Edwards DR, Wormstone IM.
|
| Invest Ophthalmol Vis Sci 53(7):4085-98. doi: 10.1167/iovs.12-9457.
2012
|
20 | MMP2
|
| Dimerization of matrix metalloproteinase-2 (MMP-2): functional implication in MMP-2 activation.
|
| Koo BH, Kim YH, Han JH, Kim DS.
|
| J Biol Chem 287(27):22643-53. doi: 10.1074/jbc.M111.337949. Epub 2012 May 10.
2012
|
21 | MMP2
|
| A novel intracellular isoform of matrix metalloproteinase-2 induced by oxidative stress activates innate immunity.
|
| Lovett DH, Mahimkar R, Raffai RL, Cape L, Maklashina E, Cecchini G, Karliner JS.
|
| PLoS One 7(4):e34177. doi: 10.1371/journal.pone.0034177. Epub 2012 Apr 3.
2012
|
22 | MMP2, S100A14
|
| Involvement of S100A14 protein in cell invasion by affecting expression and function of matrix metalloproteinase (MMP)-2 via p53-dependent transcriptional regulation.
|
| Chen H, Yuan Y, Zhang C, Luo A, Ding F, Ma J, Yang S, Tian Y, Tong T, Zhan Q, Liu Z.
|
| J Biol Chem 287(21):17109-19. doi: 10.1074/jbc.M111.326975. Epub 2012 Mar 26.
2012
|
23 | ACR, MMP2
|
| MMP2 and acrosin are major proteinases associated with the inner acrosomal membrane and may cooperate in sperm penetration of the zona pellucida during fertilization
|
| Ferrer M, Rodriguez H, Zara L, Yu Y, Xu W, Oko R.
|
| Cell Tissue Res. Sep;349(3):881-95. doi: 10.1007/s00441-012-1429-1. Epub 2012 May 22. 2012
|
24 | FOXO3, MMP2, NOX4, UTS2
|
| NOX4 mediates activation of FoxO3a and matrix metalloproteinase-2 expression by urotensin-II.
|
| Diebold I, Petry A, Burger M, Hess J, Görlach A.
|
| Mol Biol Cell 22(22):4424-34. doi: 10.1091/mbc.E10-12-0971. Epub 2011 Sep 30.
2011
|
25 | MMP2
|
| ARP101, a selective MMP-2 inhibitor, induces autophagy-associated cell death in cancer cells.
|
| Jo YK, Park SJ, Shin JH, Kim Y, Hwang JJ, Cho DH, Kim JC.
|
| Biochem Biophys Res Commun 404(4):1039-43. Epub 2010 Dec 25.
2011
|
26 | MMP2, WISP1
|
| WISP-1 increases MMP-2 expression and cell motility in human chondrosarcoma cells.
|
| Hou CH, Chiang YC, Fong YC, Tang CH.
|
| Biochem Pharmacol 81(11):1286-95. doi: 10.1016/j.bcp.2011.03.016. Epub 2011 Mar 29.
2011
|
27 | MMP2
|
| Role of AP-1 and RE-1 binding sites in matrix metalloproteinase-2 transcriptional regulation in skeletal muscle atrophy.
|
| Liu X, Manzano G, Lovett DH, Kim HT.
|
| Biochem Biophys Res Commun 396(2):219-23. Epub 2010 Apr 14.
2010
|
28 | MMP2, ZNF580
|
| Sphingosine-1-phosphate induces human endothelial VEGF and MMP-2 production via transcription factor ZNF580: novel insights into angiogenesis.
|
| Sun HY, Wei SP, Xu RC, Xu PX, Zhang WC.
|
| Biochem Biophys Res Commun 395(3):361-6. Epub 2010 Apr 9.PMID: 20382120 2010
|
29 | MMP2, WINCH
|
| A novel homozygous MMP2 mutation in a patient with Torg-Winchester syndrome.
|
| Jeong SY, Kim BY, Kim HJ, Yang JA, Kim OH.
|
| J Hum Genet 55(11):764-6. Epub 2010 Aug 19.
2010
|
30 | MMP2, NAO
|
| Clinical variability of asphyxiating thoracic dystrophy (Jeune) syndrome: Evaluation and classification of 13 patients.
|
| Tüysüz B, Bariº S, Aksoy F, Madazli R, Ungür S, Sever L.
|
| Am J Med Genet A 149A(8):1727-33.
2009
|
31 | CEP55, FOXM1, MMP2
|
| Expression of FLJ10540 is correlated with aggressiveness of oral cavity squamous cell carcinoma by stimulating cell migration and invasion through increased FOXM1 and MMP-2 activity.
|
| Chen CH, Chien CY, Huang CC, Hwang CF, Chuang HC, Fang FM, Huang HY, Chen CM, Liu HL, Huang CY.
|
| Oncogene 28(30):2723-37. Epub 2009 Jun 15.
2009
|
32 | MMP2
|
| Potential role of increased matrix metalloproteinase-2 (MMP2) transcription in impaired adipogenesis in type 2 diabetes mellitus.
|
| Dubois SG, Tchoukalova YD, Heilbronn LK, Albu JB, Kelley DE, Smith SR, Fang X, Ravussin E; Look AHEAD Adipose Research Group.
|
| Biochem Biophys Res Commun 367(4):725-8. Epub 2008 Jan 7. 2008
|
33 | MMP2, MMP9
|
| Genetic polymorphisms of matrix metalloproteinases in lung, breast and colorectal cancer.
|
| Decock J, Paridaens R, Ye S.
|
| Clin Genet 73(3):197-211. Epub 2007 Dec 29. Review. 2008
|
34 | MMP2
|
| Plasma levels of matrix metalloproteinase-2 and -9 (MMP-2 and MMP-9) in age-related macular degeneration.
|
| Chau KY, Sivaprasad S, Patel N, Donaldson TA, Luthert PJ, Chong NV.
|
| Eye 22(6):855-9. 2008
|
35 | ARHGAP5, MMP14, MMP2
|
| p190B RhoGAP regulates endothelial-cell-associated proteolysis through MT1-MMP and MMP2.
|
| Guegan F, Tatin F, Leste-Lasserre T, Drutel G, Genot E, Moreau V.
|
| J Cell Sci 121(Pt 12):2054-61. Epub 2008 May 27.PMID: 18505793 2008
|
36 | HOXA11, MMP2
|
| HOXA11 is critical for development and maintenance of uterosacral ligaments and deficient in pelvic prolapse.
|
| Connell KA, Guess MK, Chen H, Andikyan V, Bercik R, Taylor HS.
|
| J Clin Invest 118(3):1050-5.PMID: 18274672 2008
|
37 | ITGA2B, ITGB3, MMP2
|
| MMP-2 regulates human platelet activation by interacting with integrin alphaIIbbeta3.
|
| Choi WS, Jeon OH, Kim HH, Kim DS.
|
| J Thromb Haemost 6(3):517-23. Epub 2007 Dec 12.
2008
|
38 | MMP2,NAO
|
| Loss of MMP-2 disrupts skeletal and craniofacial development and results in decreased bone mineralization, joint erosion and defects in osteoblast and osteoclast growth.
|
| Mosig RA, Dowling O, Difeo A, Ramirez MC, Parker IC, Abe E, Diouri J, Aqeel AA, Wylie JD, Oblander SA, Madri J, Bianco P, Apte SS, Zaidi M, Doty SB, Majeska RJ, Schaffler MB, Martignetti JA.
|
| Hum Mol Genet 16(9):1113-23. Epub 2007 Mar 30. 2007
|
39 | SDC2, MMP2
|
| A novel function of syndecan-2, suppression of matrix metalloproteinase-2 activation, which causes suppression of metastasis.
|
| Munesue S, Yoshitomi Y, Kusano Y, Koyama Y, Nishiyama A, Nakanishi H, Miyazaki K, Ishimaru T, Miyaura S, Okayama M, Oguri K.
|
| J Biol Chem 282(38):28164-74. Epub 2007 Jul 10. 2007
|
40 | MMP2
|
| Functional polymorphisms and haplotypes in the promoter of the MMP2 gene are associated with risk of nasopharyngeal carcinoma.
|
| Zhou G, Zhai Y, Cui Y, Qiu W, Yang H, Zhang X, Dong X, He Y, Yao K, Zhang H, Peng Y, Yuan X, Zhi L, Zhang X, He F.
|
| Hum Mutat 28(11):1091-7. 2007
|
41 | MMP2, NAO, WINCH
|
| Torg syndrome is caused by inactivating mutations in MMP2 and is allelic to NAO and Winchester syndrome.
|
| Zankl A, Pachman L, Poznanski A, Bonafé L, Wang F, Shusterman Y, Fishman DA, Superti-Furga A.
|
| J Bone Miner Res 22(2):329-33.
2007
|
42 | MMP2, MMP9
|
| Fetal MMP2/MMP9 polymorphisms and intrauterine growth restriction risk.
|
| Gremlich S, Nguyen D, Reymondin D, Hohlfeld P, Vial Y, Witkin SS, Gerber S.
|
| J Reprod Immunol 74(1-2):143-51. Epub 2007 Mar 23.
2007
|
43 | MMP2, NAO
|
| A crucial role for matrix metalloproteinase 2 in osteocytic canalicular formation and bone metabolism.
|
| Inoue K, Mikuni-Takagaki Y, Oikawa K, Itoh T, Inada M, Noguchi T, Park JS, Onodera T, Krane SM, Noda M, Itohara S.
|
| J Biol Chem 281(44):33814-24. Epub 2006 Sep 7.
2006
|
44 | MMP2, WINCH, NAO
|
| A novel homozygous MMP2 mutation in a family with Winchester syndrome.
|
| Rouzier C, Vanatka R, Bannwarth S, Philip N, Coussement A, Paquis-Flucklinger V, Lambert JC.
|
| Clin Genet 69(3):271-6. 2006
|
45 | MMP2
|
| Chitooligosaccharides inhibit activation and expression of matrix metalloproteinase-2 in human dermal fibroblasts.
|
| Kim MM, Kim SK.
|
| FEBS Lett 580(11):2661-6. Epub 2006 Apr 21. 2006
|
46 | CCL23, MMP2
|
| Human CC chemokine CCL23 enhances expression of matrix metalloproteinase-2 and invasion of vascular endothelial cells.
|
| Son KN, Hwang J, Kwon BS, Kim J.
|
| Biochem Biophys Res Commun 340(2):498-504. Epub 2005 Dec 19. 2006
|
47 | TIMP1, MMP2
|
| Keratoconus: matrix metalloproteinase-2 activation and TIMP modulation.
|
| Smith VA, Matthews FJ, Majid MA, Cook SD.
|
| Biochim Biophys Acta 1762(4):431-9. Epub 2006 Feb 17. 2006
|
48 | MMP2
|
| Genes associated with adult axon regeneration promoted by olfactory ensheathing cells: a new role for matrix metalloproteinase 2.
|
| Pastrana E, Moreno-Flores MT, Gurzov EN, Avila J, Wandosell F, Diaz-Nido J.
|
| J Neurosci 26(20):5347-59. 2006
|
49 | MMP2, TIMP1
|
| MMP-9 and MMP-2 gelatinases and TIMP-1 and TIMP-2 inhibitors in breast cancer: correlations with prognostic factors.
|
| Jinga DC, Blidaru A, Condrea I, Ardeleanu C, Dragomir C, Szegli G, Stefanescu M, Matache C.
|
| J Cell Mol Med 10(2):499-510. 2006
|
50 | MMP2, NAO, WINCH
|
| Winchester syndrome caused by a homozygous mutation affecting the active site of matrix metalloproteinase 2.
|
| Zankl A, Bonafe L, Calcaterra V, Di Rocco M, Superti-Furga A.
|
| Clin Genet 67(3):261-6. 2005
|
51 | SFD, TIMP3, MMP2
|
| Sorsby's fundus dystrophy mutations impair turnover of TIMP-3 by retinal pigment epithelial cells.
|
| Langton KP, McKie N, Smith BM, Brown NJ, Barker MD.
|
| Hum Mol Genet 14(23):3579-86. Epub 2005 Oct 13. 2005
|
52 | MMP2
|
| MMP-2 levels are elevated in the plasma of women who subsequently develop preeclampsia.
|
| Myers JE, Merchant SJ, Macleod M, Mires GJ, Baker PN, Davidge ST.
|
| Hypertens Pregnancy 24(2):103-15. 2005
|
53 | MMP2, MMP9
|
| Functional basis for the overlap in ligand interactions and substrate specificities of matrix metalloproteinases-9 and -2.
|
| Xu X, Chen Z, Wang Y, Yamada Y, Steffensen B.
|
| Biochem J 392(Pt 1):127-34. 2005
|
54 | MMP1, MMP10, MMP11, MMP12, MMP13, MMP14, MMP15, MMP16, MMP17, MMP19, MMP2, MMP20, MMP21, MMP23A, MMP23B, MMP24, MMP25, MMP26, MMP27, MMP28, MMP3, MMP7, MMP8, MMP9
|
| Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry.
|
| Visse R, Nagase H.
|
| Circ Res 92(8):827-39. Review. 2003
|
55 | MMP2, APP
|
| Identification of a region of beta-amyloid precursor protein essential for its gelatinase A inhibitory activity.
|
| Higashi S, Miyazaki K.
|
| J Biol Chem 278(16):14020-8. Epub 2003 Feb 13. 2003
|
56 | MMP2, MMP9
|
| Matrix metalloproteinases 2 and 9 (gelatinases A and B) expression in malignant mesothelioma and benign pleura.
|
| Edwards JG, McLaren J, Jones JL, Waller DA, O'Byrne KJ.
|
| Br J Cancer 88(10):1553-9. 2003
|
57 | CCN3, MMP2, PDGFRA
|
| NOVH increases MMP3 expression and cell migration in glioblastoma cells via a PDGFR-alpha-dependent mechanism.
|
| Laurent M, Martinerie C, Thibout H, Hoffman MP, Verrecchia F, Le Bouc Y, Mauviel A, Kleinman HK.
|
| FASEB J 17(13):1919-21. Epub 2003 Aug 15. 2003
|
58 | MMP2
|
| Matrix metalloproteinase-2 (MMP-2) is associated with survival in breast carcinoma.
|
| Talvensaari-Mattila A, Paakko P, Turpeenniemi-Hujanen T.
|
| Br J Cancer 89(7):1270-5. 2003
|
59 | MMP2, TIMP2
|
| Increased expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 is correlated with poor prognostic variables in patients with thymic epithelial tumors.
|
| Sogawa K, Kondo K, Fujino H, Takahashi Y, Miyoshi T, Sakiyama S, Mukai K, Monden Y.
|
| Cancer 98(9):1822-9. 2003
|
60 | ATF3, MMP2
|
| ATF3 represses 72-kDa type IV collagenase (MMP-2) expression by antagonizing p53-dependent trans-activation of the collagenase promoter.
|
| Yan C, Wang H, Boyd DD.
|
| J Biol Chem 277(13):10804-12. 2002
|
61 | MMP2
|
| The significance of membrane type 1 metalloproteinase in structural involution of human corpora lutea.
|
| Manase K, Endo T, Henmi H, Kitajima Y, Yamazaki K, Nishikawa A, Mitaka T, Sato H, Kudo R.
|
| Mol Hum Reprod 8(8):742-9. 2002
|
62 | MMP2, MMP14, TIMP2
|
| Regulation of endothelial matrix metalloproteinase-2 by hypoxia/reoxygenation.
|
| Ben-Yosef Y, Lahat N, Shapiro S, Bitterman H, Miller A.
|
| Circ Res 90(7):784-91. 2002
|
63 | MMP2
|
| Identification of novel, functional genetic variants in the human matrix metalloproteinase-2 gene: role of Sp1 in allele-specific transcriptional regulation.
|
| Price SJ, Greaves DR, Watkins H.
|
| J Biol Chem 276(10):7549-58. 2001
|
64 | MMP2, NAO
|
| Mutation of the matrix metalloproteinase 2 gene (MMP2) causes a multicentric osteolysis and arthritis syndrome.
|
| Martignetti JA, Aqeel AA, Sewairi WA, Boumah CE, Kambouris M, Mayouf SA, Sheth KV, Eid WA, Dowling O, Harris J, Glucksman MJ, Bahabri S, Meyer BF, Desnick RJ.
|
| Nat Genet 28(3):261-5. 2001
|
65 | MMP2, PTEN
|
| Suppression of matrix metalloproteinase-2 gene expression and invasion in human glioma cells by MMAC/PTEN.
|
| Koul D, Parthasarathy R, Shen R, Davies MA, Jasser SA, Chintala SK, Rao JS, Sun Y, Benvenisite EN, Liu TJ, Yung WK.
|
| Oncogene 20(46):6669-78. 2001
|
66 | MMP2
|
| Matrix metalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumor model.
|
| Fang J, Shing Y, Wiederschain D, Yan L, Butterfield C, Jackson G, Harper J, Tamvakopoulos G, Moses MA.
|
| Proc Natl Acad Sci U S A 97(8):3884-9. 2000
|
67 | MMP14, MMP2
|
| Expression of matrix metalloproteinase-2 (MMP-2) and of membrane-type-1-matrix metalloproteinase (MT1-MMP) in transitional cell carcinoma of the upper urinary tract.
|
| Nakanishi K, Kawai T, Sato H, Aida S, Kasamatsu H, Aurues T, Ikeda T.
|
| Hum Pathol 31(2):193-200. 2000
|
68 | MMP2, MMP9
|
| Expression of matrix metalloproteinases in the muscle of patients with inflammatory myopathies.
|
| Choi YC, Dalakas MC.
|
| Neurology 54(1):65-71. 2000
|
69 | MMP2, TIMP2
|
| Localization and quantification of mRNA for matrix metalloproteinase-2 (MMP-2) and tissue inhibitor of matrix metalloproteinase-2 (TIMP-2) in human benign and malignant prostatic tissue.
|
| Still K, Robson CN, Autzen P, Robinson MC, Hamdy FC.
|
| Prostate 42(1):18-25. 2000
|
70 | MMP14, MMP2, TIMP2
|
| Binding of active (57 kDa) membrane type 1-matrix metalloproteinase (MT1-MMP) to tissue inhibitor of metalloproteinase (TIMP)-2 regulates MT1-MMP processing and pro-MMP-2 activation.
|
| Hernandez-Barrantes S, Toth M, Bernardo MM, Yurkova M, Gervasi DC, Raz Y, Sang QA, Fridman R.
|
| J Biol Chem 275(16):12080-9. 2000
|
71 | CSF2, MMP14, MMP2
|
| Granulocyte-macrophage colony-stimulating factor upregulates matrix metalloproteinase-2 (MMP-2) and membrane type-1 MMP (MT1-MMP) in human head and neck cancer cells.
|
| Tomita T, Fujii M, Tokumaru Y, Imanishi Y, Kanke M, Yamashita T, Ishiguro R, Kanzaki J, Kameyama K, Otani Y.
|
| Cancer Lett 156(1):83-91. 2000
|
72 | MMP2, SPI1
|
| The hematopoietic transcription factor PU.1 represses gelatinase A transcription in glomerular mesangial cells.
|
| Harendza S, Lovett DH, Stahl RA.
|
| J Biol Chem 275(26):19552-9. 2000
|
73 | MMP2, MMP9
|
| Expression of matrix metalloproteinases 2 and 9 in regenerating skeletal muscle: a study in experimentally injured and mdx muscles.
|
| Kherif S, et al.
|
| Dev Biol 205(1):158-70. 1999
|
74 | MMP2
|
| Structure of human pro-matrix metalloproteinase-2: activation mechanism revealed.
|
| Morgunova E, et al.
|
| Science 284(5420):1667-70. 1999
|
75 | MMP2, MMP9, MMP14
|
| Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas.
|
| Forsyth PA, et al.
|
| Br J Cancer 79(11-12):1828-35. 1999
|
76 | MMP1, MMP2, MMP9
|
| Matrix metalloproteinase levels are elevated in inflammatory bowel disease.
|
| Baugh MD, Perry MJ, Hollander AP, Davies DR, Cross SS, Lobo AJ, Taylor CJ, Evans GS.
|
| Gastroenterology 117(4):814-22 1999
|
77 | MMP2, MMP9
|
| Expression of basement membrane antigens and matrix metalloproteinases 2 and 9 in cutaneous basal and squamous cell carcinomas.
|
| Dumas V, Kanitakis J, Charvat S, Euvrard S, Faure M, Claudy A.
|
| Anticancer Res 19(4B):2929-38. 1999
|
78 | CDH1, CDKN1A, KIT, MMP2, TFAP2A
|
| Loss of AP-2 results in up-regulation of MCAM/MUC18 and an increase in tumor growth and metastasis of human melanoma cells.
|
| Jean D, et al.
|
| J Biol Chem 273 : 16501-16508. 1998
|
79 | MMP2
|
| Localization and translocation of MMP-2 during aggregation of human platelets.
|
| Sawicki G, Sanders EJ, Salas E, Wozniak M, Rodrigo J, Radomski MW.
|
| Thromb Haemost 80 : 836-839. 1998
|
80 | MMP2, MMP9
|
| Gelatinase (MMP-2 and -9) expression in gastrointestinal malignancy.
|
| Parsons SL, et al.
|
| Br J Cancer 78 : 1495-1502. 1998
|
81 | MMP2
|
| Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity.
|
| Brooks PC, Silletti S, von Schalscha TL, Friedlander M, Cheresh DA.
|
| Cell 92(3):391-400 1998
|
82 | MMP2
|
| Assignment of human membrane-type matrix metalloproteinase-2 (MT2-MMP) gene to 16q12 by FISH and PCR-based human/rodent cell hybrid mapping panel analysis.
|
| Yasumitsu H, Shofuda K, Nishihashi A, Eki T, Koshikawa N, Mizushima H, Miyazaki K.
|
| DNA Res 4(1):77-9. 1997
|
83 | MMP2
|
| Structure and expression of neutrophil gelatinase cDNA. Identity with type IV collagenase from HT1080 cells.
|
| Devarajan P, et al.
|
| J Biol Chem 267 : 25228-25232. 1992
|
84 | MMP2, MMP9
|
| On the structure and chromosome location of the 72- and 92-kDa human type IV collagenase genes.
|
| Collier IE, et al.
|
| Genomics 9 : 429-434. 1991
|
85 | MMP2
|
| Completion of the primary structure of the human type IV collagenase preproenzyme and assignment of the gene (CLG4) to the q21 region of chromosome 16.
|
| Huhtala P, et al.
|
| Genomics 6 : 554-559. 1990
|